Increased colonic permeability in patients with ulcerative colitis: An in vitro study

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 7, 1998, Pages 749-753

  Nejdfors, P ^a   Wang, Q ^b   Ekelund, M ^b   Westrom, B R ^b   Jansson, O ^b   Lindstrom C L ^b   Karlsson, B ^b   Jeppsson, B ^b  

^a LUND UNIVERSITY   (Sweden)

^b NONE

Author keywords

Epithelium; Human; Inflammation; Intestine; Mannitol; Ovalbumin; Ussing chamber

Indexed keywords

ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HUMAN; HUMAN TISSUE; INTESTINE EPITHELIUM; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CELL MEMBRANE PERMEABILITY; COLECTOMY; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; CULTURE TECHNIQUES; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MANNITOL; MIDDLE AGED; OVALBUMIN; REFERENCE VALUES;

EID: 0031852305     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850171701     Document Type: Article

References (31)

1. Gardiner KR, Halliday MI, Barcley GR, Milne L, Brown D, Stephens S, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995;36:897-901.
2. Ambrose NS, Johnson M, Burdon DW, Keighley MRB. Incidence of pathogenic bacteria from mesenteric lymph nodes and ilea serosa during Crohn's disease surgery. Br J Surg 1984; 71:261-7.
3. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986;105:883-5.
4. Olaison G, Sjodahl R, Tagesson C. Abnormal intestinal permeability in Crohn's disease. A possible pathogenic factor. Scand J Gastroenterol 1990;25:321-8.
5. Bjarnason I, O'Morain C, Levi AJ, Peters TJ. Absorption of chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 1983;85:318-22.
6. 99MTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease. Am J Gastroenterol 1986;81:767-70.
7. 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol 1987;82:1159-64.
8. Chadwick VS, Phillips SF, Hofmann AF. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 1977; 73:247-51.
9. Olaison G, Sjödahl R, Tagesson C. Decreased gastrointestinal absorption of peroral polyethyleneglycols (PEG 1000) in Crohn's disease. A sign of jejunal abnormality. Acta Chir Scand 1987;153:373-7.
10. Isley JK, Sanders AP, Sharpe KW, Reeves RJ, Baylin GJ. The use of radioactive isotopes in the study of colonic absorption. Am J Roentgenol 1959;81:89-92.
11. Levitan R, Bikerman V, Burrows BA, Ingelfinger FJ. Rectosigmoidal absorption of phenolsulfonphtalein (PSP), sultisoxazole diethanolamine (Gantrisin) and radioiodine (I 131) in normal subjects and patients with idiopathic ulcerative colitis. J Lab Clin Med 1963;62:639-45.
12. O'Morain C, Abelow AC, Chervu LR, Fleischner GM, Das KM. Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med 1986;108:430-5.
13. 51Cr-EDTA in patients with active inflammatory bowel disease. Clin Invest Med 1988;11:151-5.
14. Halme L, Edgren J, Turpeinen U, Von Smitten K, Stenman U-H. Urinary excretion of iohexol as a marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 1997;32:148-52.
15. Aimer S, Franzén L, Olaison G, Smeds K, Ström M. Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis. Gut 1993;34:509-13.
16. Thomas MA, Hollander D, Krugliau P, Katz K. PEG 400, a hydrophilic molecular probe for measuring intestinal permeability. Gastroenterology 1990;98:39-46.
17. Grass GM, Sweetana SA. In vitro measurement of gastrointestinal tissue permeability using a new diffusion cell. Pharmacol Res 1988;5:372-6.
18. Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29:21-37.
19. Aranow JS, Fink MP. Determinants of intestinal barrier failure in critical illness. Br J Anaesth 1996;77:71-81.
20. 2 microglobulin transgenic rats. Scand J Gastroenterol 1997;32: 700-5.
21. Munkholm P, Langholtz E, Hollander D, Thornberg K, Orholm M, Katz KD, et al. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 1994;35:68-72.
22. Gardiner KR, Anderson NH, Rowlands BJ, Barbul A. Colitis and colonic mucosal barrier dysfunction. Gut 1995;37:530-5.
23. 51Cr-EDTA absorption during experimental colitis in the rat. Dig Dis Sci 1994;39:2327-33.
24. Yamada T, Sartor RB, Marshall S, Specian RD, Grisham MB. Mucosal injury and inflammation in a model chronic granulomatous colitis in rats. Gastroenterology 1993;104:759-71.
25. 51Cr-labeled ethylenediaminetetraacetic acid in experimental colitis of rats. Scand J Gastroenterol 1996;31:140-6.
26. Pullan RD, Thomas GAO, Rhodes M, Newcombe RG, Williams GT, Allen A, et al. Thickness of adherent mucos gel on colonic mucosa in humans and its relevance to colitis. Gut 1994;35:353-9.
27. van der Waaij D, Berghuis-deVries JM, Leekkerkerk-van der Wees JEC. Colonization resistance of the digestive tract in conventional and antibiotic treated mice. J Hygiene 1971;69:405-11.
28. Marshall JC, Sweeney D. Microbial infection and the septic response in critical surgical illness. Arch Surg 1990;125:17-23.
29. Marshall JC, Christou NV, Meakins JL. The microbiology of multiple organ failure: the proximal gastrointestinal tract as an occult reservoir of pathogens. Arch Surg 1988;123:309-15.
30. Johnston JD, Harvey CJ, Menzies IS, Treacher DF. Gastrointestinal permeability and absorptive capacity in sepsis. Crit Care Med 1996;24:1144-9.
31. Krugliak P, Hollander D, Schlaepfer CC, Nguyen H, Ma TY. Mechanisms and sites of mannitol permeability of small and large intestine in the rat. Dig Dis Sci 1994;39:796-801.